Validation of the International Prostate Symptom Score in Chinese males and females with lower urinary tract symptoms
- PMID: 24382363
- PMCID: PMC3883473
- DOI: 10.1186/1477-7525-12-1
Validation of the International Prostate Symptom Score in Chinese males and females with lower urinary tract symptoms
Abstract
Objectives: To evaluate the translation of the IPSS (Hong Kong Chinese version 1) and to assess the applicability, validity, reliability and sensitivity of the instrument in both males and females with LUTS in Chinese population.
Methods: The translation of the IPSS (Hong Kong Chinese version 1) was reviewed through back translation. Modifications were made, resulting in the development of The IPSS (Hong Kong Chinese version 2). The content validity was assessed by contend validity index. 233 subjects with LUTS were recruited in Hong Kong primary care settings for pilot psychometric testing. The construct validity was assessed by corrected item-total correlation and Pearson's correlation test against ICIQ-UI SF, IIQ-7 and SF-12 v2. The reliability was assessed by the internal consistency (Cronbach's Alpha coefficient) and test -retest reliability (Intraclass correlation coefficient). The Sensitivity was determined by performing known group comparisons by independent T-test.
Results: The content validity index for all items could reach 1. Corrected item-total correlation scores were ≥0.4 for four symptom questions (feeling of incomplete bladder emptying, intermittency, weak stream and straining). Overall, the total symptom score moderately correlated with ICIQ-UI SF. The quality of life score moderately correlated with the IIQ-7 but weakly correlated with SF-12 v2. Overall, the reliability of the IPSS (Hong Kong Chinese version 2) was acceptable (Cronbach's Alpha coefficient = 0.71, ICC of the symptom questions =0.8, ICC of the quality of life question =0.7). The symptoms questions and quality of life questions of the IPSS (Hong Kong Chinese versions 2) were sensitive in detecting differences between groups.
Conclusions: The IPSS (Hong Kong Chinese version 2) is a valid, reliable and sensitive measure to assess Chinese females and males with lower urinary tract symptoms. The IPSS quality of life question is more sensitive than the generic quality of life measure to differentiate subgroups.
Similar articles
-
The incontinence impact questionnaire-7 (IIQ-7) can be applicable to Chinese males and females with lower urinary tract symptoms.Patient. 2014;7(4):403-11. doi: 10.1007/s40271-014-0062-3. Patient. 2014. PMID: 24866274
-
Translation and validation into Brazilian Portuguese of the English version of the International Consultation on Incontinence Modular Questionnaire for Male Lower Urinary Tract Symptoms (ICIQ-MLUTS).Neurourol Urodyn. 2024 Jan;43(1):63-68. doi: 10.1002/nau.25299. Epub 2023 Oct 25. Neurourol Urodyn. 2024. PMID: 37876359
-
Development and validation of the International Consultation on Incontinence Modular Questionnaire for Male Lower Urinary Tract Symptoms (ICIQ-MLUTS) and the ICIQ-MLUTS Long Form in Chinese population.Low Urin Tract Symptoms. 2019 Sep;11(4):189-194. doi: 10.1111/luts.12260. Epub 2019 Apr 3. Low Urin Tract Symptoms. 2019. PMID: 30945458
-
How international is the International Prostate Symptom Score? A literature review of validated translations of the IPSS, the most widely used self-administered patient questionnaire for male lower urinary tract symptoms.Low Urin Tract Symptoms. 2022 Mar;14(2):92-101. doi: 10.1111/luts.12415. Epub 2021 Nov 3. Low Urin Tract Symptoms. 2022. PMID: 34734477 Review.
-
Perinatal Incontinence Assessment Tools: A Psychometric Evaluation and Scoping Review.J Womens Health (Larchmt). 2022 Aug;31(8):1208-1218. doi: 10.1089/jwh.2021.0353. Epub 2022 Feb 25. J Womens Health (Larchmt). 2022. PMID: 35230163 Review.
Cited by
-
Prevalence of Double Incontinence and Lower Urinary Tract Symptoms in Patients with Fecal Incontinence: A Single-center Observational Study.J Anus Rectum Colon. 2024 Jan 25;8(1):30-38. doi: 10.23922/jarc.2023-040. eCollection 2024. J Anus Rectum Colon. 2024. PMID: 38313750 Free PMC article.
-
Triptorelin therapy for lower urinary tract symptoms (LUTS) in prostate cancer patients: A systematic meta-analysis.BJUI Compass. 2023 Oct 10;5(1):17-28. doi: 10.1002/bco2.292. eCollection 2024 Jan. BJUI Compass. 2023. PMID: 38179030 Free PMC article. Review.
-
Reliability and validity of the Tibetan version of the International Prostate Symptom Score.World J Urol. 2023 May;41(5):1389-1394. doi: 10.1007/s00345-023-04368-1. Epub 2023 Apr 11. World J Urol. 2023. PMID: 37039905
-
Skin sympathetic nerve activity as a potential biomarker for overactive bladder.World J Urol. 2023 May;41(5):1373-1379. doi: 10.1007/s00345-023-04376-1. Epub 2023 Mar 27. World J Urol. 2023. PMID: 36971826
-
Simplified Chinese version of the international prostate symptom score and the benign prostatic hyperplasia impact index: cross-cultural adaptation, reliability, and validity for patients with benign prostatic hyperplasia.Prostate Int. 2022 Sep;10(3):162-168. doi: 10.1016/j.prnil.2022.04.001. Epub 2022 May 10. Prostate Int. 2022. PMID: 36225281 Free PMC article.
References
-
- Barry MJ, Fowler FJ Jr, O’Leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK, Cockett AT. The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J Urol. 1992;148:1549–1557. discussion 1564. - PubMed
-
- Gregoire JP, Moisan J, Labrecque M, Cusan L, Diamond P. Validation of a French adaptation of the international prostatic symptom score. Prog Urol. 1996;6:240–249. - PubMed
-
- Homma Y, Tsukamoto T, Yasuda K, Ozono S, Yoshida M, Yamaguchi T. Evaluation of psychometric properties of Japanese version of international prostate symptom score and BPH impact index. Nihon Hinyokika Gakkai Zasshi. 2003;94:560–569. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
